AR094389A1 - USO DE INHIBIDORES DE iNOS PARA AUMENTAR EL RENDIMIENTO VÍRICO EN CULTIVOS - Google Patents
USO DE INHIBIDORES DE iNOS PARA AUMENTAR EL RENDIMIENTO VÍRICO EN CULTIVOSInfo
- Publication number
- AR094389A1 AR094389A1 ARP140100065A ARP140100065A AR094389A1 AR 094389 A1 AR094389 A1 AR 094389A1 AR P140100065 A ARP140100065 A AR P140100065A AR P140100065 A ARP140100065 A AR P140100065A AR 094389 A1 AR094389 A1 AR 094389A1
- Authority
- AR
- Argentina
- Prior art keywords
- virus
- increase
- vivic
- crops
- performance
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 title 1
- 101710089543 Nitric oxide synthase, inducible Proteins 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 3
- 102000011779 Nitric Oxide Synthase Type II Human genes 0.000 abstract 2
- 108010076864 Nitric Oxide Synthase Type II Proteins 0.000 abstract 2
- NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical compound CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 abstract 2
- GIXWDMTZECRIJT-UHFFFAOYSA-N aurintricarboxylic acid Chemical compound C1=CC(=O)C(C(=O)O)=CC1=C(C=1C=C(C(O)=CC=1)C(O)=O)C1=CC=C(O)C(C(O)=O)=C1 GIXWDMTZECRIJT-UHFFFAOYSA-N 0.000 abstract 2
- 241001529453 unidentified herpesvirus Species 0.000 abstract 2
- 208000009889 Herpes Simplex Diseases 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 abstract 1
- 229960003957 dexamethasone Drugs 0.000 abstract 1
- 229960000604 valproic acid Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16641—Use of virus, viral particle or viral elements as a vector
- C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16651—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361750175P | 2013-01-08 | 2013-01-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR094389A1 true AR094389A1 (es) | 2015-07-29 |
Family
ID=51167323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140100065A AR094389A1 (es) | 2013-01-08 | 2014-01-08 | USO DE INHIBIDORES DE iNOS PARA AUMENTAR EL RENDIMIENTO VÍRICO EN CULTIVOS |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11299715B2 (https=) |
| EP (3) | EP3521420A1 (https=) |
| JP (2) | JP6534933B2 (https=) |
| KR (1) | KR102307279B1 (https=) |
| CN (1) | CN105008523B (https=) |
| AR (1) | AR094389A1 (https=) |
| AU (1) | AU2014205604B2 (https=) |
| BR (2) | BR112015016328B1 (https=) |
| CA (1) | CA2897444A1 (https=) |
| DK (1) | DK2943567T3 (https=) |
| ES (1) | ES2651763T3 (https=) |
| HK (1) | HK1249544A1 (https=) |
| HU (1) | HUE037482T2 (https=) |
| IL (1) | IL239824B (https=) |
| MX (2) | MX360470B (https=) |
| NO (1) | NO3050055T3 (https=) |
| RU (1) | RU2676733C2 (https=) |
| SG (3) | SG11201505333PA (https=) |
| TW (1) | TWI608102B (https=) |
| WO (1) | WO2014110053A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2716991C2 (ru) | 2014-11-05 | 2020-03-17 | Вояджер Терапьютикс, Инк. | Полинуклеотиды aadc для лечения болезни паркинсона |
| KR20230145206A (ko) | 2014-11-14 | 2023-10-17 | 보이저 테라퓨틱스, 인크. | 조절성 폴리뉴클레오티드 |
| WO2016077687A1 (en) | 2014-11-14 | 2016-05-19 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| US11697825B2 (en) | 2014-12-12 | 2023-07-11 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scAAV |
| FI3436593T3 (fi) | 2016-03-28 | 2023-03-16 | Ultragenyx Pharmaceutical Inc | Adenoviruksen lämpöinaktivointimenetelmiä |
| KR20240056729A (ko) | 2016-05-18 | 2024-04-30 | 보이저 테라퓨틱스, 인크. | 조절성 폴리뉴클레오티드 |
| PL3526321T3 (pl) | 2016-10-14 | 2025-04-28 | Ultragenyx Pharmaceutical Inc. | Zastosowanie środków regulujących ciśnienie osmotyczne w celu zwiększenia wydajności rekombinacyjnego wirusa związanego z adenowirusami |
| WO2018175775A1 (en) | 2017-03-22 | 2018-09-27 | Dimension Therapeutics | Cell culture methods involving hdac inhibitors or rep proteins |
| WO2018208960A1 (en) | 2017-05-09 | 2018-11-15 | Dimension Therapeutics, Inc. | Scalable method for producing transfection reagents |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| KR20210019996A (ko) | 2018-05-15 | 2021-02-23 | 보이저 테라퓨틱스, 인크. | 파킨슨병의 치료를 위한 조성물 및 방법 |
| CN110835622B (zh) * | 2018-08-16 | 2021-04-27 | 上海药明生物技术有限公司 | 用于调节哺乳动物细胞乳酸代谢的培养基及其应用 |
| EP3856762A1 (en) | 2018-09-28 | 2021-08-04 | Voyager Therapeutics, Inc. | Frataxin expression constructs having engineered promoters and methods of use thereof |
| AU2021239973A1 (en) | 2020-03-16 | 2022-10-06 | Ultragenyx Pharmaceutical Inc. | Methods for enhancing recombinant adeno-associated virus yield |
| CN118871575A (zh) * | 2022-02-21 | 2024-10-29 | 学校法人日本医科大学 | 病毒载体生产增强剂及产生病毒载体的方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| AU8200191A (en) | 1990-07-09 | 1992-02-04 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | High efficiency packaging of mutant adeno-associated virus using amber suppressions |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| RU2012335C1 (ru) * | 1991-07-04 | 1994-05-15 | Уфимский научно-исследовательский институт глазных болезней | Ингибитор вируса простого герпеса |
| DE69233013T2 (de) | 1991-08-20 | 2004-03-04 | The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer | Adenovirus vermittelter gentransfer in den gastrointestinaltrakt |
| WO1994003207A1 (en) * | 1992-07-31 | 1994-02-17 | President And Fellows Of Harvard College | Herpesvirus vaccines |
| US7223411B1 (en) | 1992-07-31 | 2007-05-29 | Dana-Farber Cancer Institute | Herpesvirus replication defective mutants |
| US6833271B2 (en) | 1996-12-04 | 2004-12-21 | Medi-Cult A/S | Serum-free cell culture media |
| GB9816856D0 (en) * | 1998-08-03 | 1998-09-30 | Univ London | Cell lines for virus growth |
| US6783972B1 (en) * | 1998-09-22 | 2004-08-31 | University Of Florida Research Foundation | Methods for large-scale production of recombinant AAV vectors |
| US6593123B1 (en) | 2000-08-07 | 2003-07-15 | Avigen, Inc. | Large-scale recombinant adeno-associated virus (rAAV) production and purification |
| US7091029B2 (en) * | 2002-09-23 | 2006-08-15 | Applied Genetics Technologies Corporation | High titer recombinant AAV production |
| US7427396B2 (en) | 2004-06-03 | 2008-09-23 | Genzyme Corporation | AAV vectors for gene delivery to the lung |
| CN100348718C (zh) * | 2005-10-18 | 2007-11-14 | 中国人民解放军军事医学科学院生物工程研究所 | 一种支持hek293细胞贴附培养的无动物来源成分无血清培养基 |
| ES2533863T3 (es) * | 2007-06-29 | 2015-04-15 | Korea Research Institute Of Chemical Technology | Inhibidores novedosos de la transcriptasa inversa de VIH |
-
2014
- 2014-01-07 EP EP19160865.2A patent/EP3521420A1/en not_active Withdrawn
- 2014-01-07 MX MX2015008861A patent/MX360470B/es active IP Right Grant
- 2014-01-07 KR KR1020157021175A patent/KR102307279B1/ko active Active
- 2014-01-07 RU RU2015133205A patent/RU2676733C2/ru active
- 2014-01-07 SG SG11201505333PA patent/SG11201505333PA/en unknown
- 2014-01-07 HU HUE14703459A patent/HUE037482T2/hu unknown
- 2014-01-07 ES ES14703459.9T patent/ES2651763T3/es active Active
- 2014-01-07 AU AU2014205604A patent/AU2014205604B2/en not_active Ceased
- 2014-01-07 CN CN201480012376.2A patent/CN105008523B/zh active Active
- 2014-01-07 JP JP2015551846A patent/JP6534933B2/ja active Active
- 2014-01-07 CA CA2897444A patent/CA2897444A1/en not_active Abandoned
- 2014-01-07 EP EP14703459.9A patent/EP2943567B1/en active Active
- 2014-01-07 BR BR112015016328-9A patent/BR112015016328B1/pt active IP Right Grant
- 2014-01-07 DK DK14703459.9T patent/DK2943567T3/en active
- 2014-01-07 SG SG10201913130PA patent/SG10201913130PA/en unknown
- 2014-01-07 MX MX2018013366A patent/MX378877B/es unknown
- 2014-01-07 US US14/758,785 patent/US11299715B2/en active Active
- 2014-01-07 WO PCT/US2014/010553 patent/WO2014110053A1/en not_active Ceased
- 2014-01-07 SG SG10201806715TA patent/SG10201806715TA/en unknown
- 2014-01-07 BR BR122020002822-0A patent/BR122020002822B1/pt active IP Right Grant
- 2014-01-07 EP EP17184746.0A patent/EP3266866B1/en active Active
- 2014-01-07 TW TW103100466A patent/TWI608102B/zh active
- 2014-01-08 AR ARP140100065A patent/AR094389A1/es unknown
- 2014-09-26 NO NO14781027A patent/NO3050055T3/no unknown
-
2015
- 2015-07-07 IL IL239824A patent/IL239824B/en active IP Right Grant
-
2018
- 2018-07-10 HK HK18108963.6A patent/HK1249544A1/en unknown
-
2019
- 2019-05-28 JP JP2019098958A patent/JP6837094B2/ja active Active
-
2022
- 2022-03-03 US US17/686,245 patent/US20220340883A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR094389A1 (es) | USO DE INHIBIDORES DE iNOS PARA AUMENTAR EL RENDIMIENTO VÍRICO EN CULTIVOS | |
| BR112015001637A2 (pt) | método usando microalgas para produção com eficiência elevada de astaxantina | |
| CO7170149A2 (es) | Producción mejorada de derivados de ácidos grasos | |
| AR103161A1 (es) | Anticuerpos antimiostatina y regiones fc variantes así como métodos de uso | |
| MX2012013037A (es) | Composiciones de endorribonucleasa y metodos de uso de las mismas. | |
| MX2016015004A (es) | Uso de moleculas pequeñas para mejorar la expresion de mafa en celulas endocrinas pancreaticas. | |
| GB2548740A (en) | Methods for generation of podocytes from pluripotent stem cells and cells produced by the same | |
| EA201492183A1 (ru) | Клетки для получения рекомбинантной идуронат-2-сульфатазы | |
| BR112016014488A2 (pt) | Meio para cultura celular | |
| CU20160159A7 (es) | Proceso de cultivo celular regulado de células eucariotas y productos derivados y método de generación de material celular vegetal en forma de un paquete celular multicapa no tejido y estructurado poroso, privado del medio | |
| WO2014087244A3 (en) | Methods of producing rpe cells | |
| CA2886946C (en) | Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour | |
| AR116615A2 (es) | Operaciones de cosecha mejoradas para proteínas recombinadas | |
| BR112016028512A8 (pt) | método de cultivo de uma célula de mamífero e método de produção de uma proteína recombinante | |
| MX2018006373A (es) | Produccion de virus en cultivos celulares. | |
| MX384031B (es) | Parches de células musculares y usos para los mismos. | |
| MX2016005824A (es) | Metodo de cultivo celular. | |
| MX2018006627A (es) | Aumentar el rendimiento de particulas similares a virus en plantas. | |
| MX2016008258A (es) | Celulas eucariotas novedosas y metodos para la expresion recombinante de un producto de interes. | |
| NZ611531A (en) | Bovine viral diarrhea virus type 1b vaccine compositions and methods | |
| BR112014019328A8 (pt) | Perfil de fenótipo de células progenitoras retinais humanas | |
| CL2010000774A1 (es) | Medio para el cultivo de celulas de mamiferos que comprende ademas de los nutrientes habituales de los medios de cultivo basales para cultivo de celulas de mamiferos, sobrenadante de la fraccion ii+iii del plasma humano segun el metodo de cohn; procedimiento de preparacion; y su uso. | |
| AR069885A1 (es) | Metodos para producir el virus de estomatitis vesicular (vsv) atenuado en un cultivo celular y para mejorar el empaque del vsv de propagacion defectuosa, composicion inmunogenica, celula aislada y secuencia de control transcripcional | |
| MX2013010997A (es) | Ensayo para clasificacion de compuestos que disminuyen selectivamente el numero de celulas madre de cance. | |
| CL2018000076A1 (es) | Mejora del metabolismo de las microalgas de xilosa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |